Non-Small Cell Lung Carcinoma

Details 574 Trials 141 Therapies

A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.

parent conditions

Lung Carcinoma

child conditions

Squamous Cell Lung Carcinoma

Non-Squamous Non-Small Cell Lung Carcinoma

synonyms

NSCLC

Non Small Cell Carcinoma

Non-Small Cell Lung Cancer

lung cancer (non-small cell)

Non-Small Cell Cancer of Lung

Non-Small Cell Lung Carcinoma

Non Small Cell Lung Cancer NOS

Non-small cell lung cancer, NOS

Non-Small Cell Carcinoma of Lung

Non-Small Cell Cancer of the Lung

NSCLC - Non-Small Cell Lung Cancer

Non-Small Cell Carcinoma of the Lung

Non-small cell lung carcinoma (NSCLC)

Lung non-small cell lung carcinoma (NOS)

A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure

227 sites for NCT04988295

EGFR Exon 19 Deletion, +1 more biomarker

Non-Squamous Non-Small Cell Lung Carcinoma

amivantamab, +3 more drugs

chemotherapy, +1 more type

Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).

173 sites for NCT03164616

Non-Small Cell Lung Carcinoma

carboplatin, +6 more drugs

chemotherapy, +1 more type

A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

173 sites for NCT04819100

RET Fusion

Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

259 sites for NCT04487080

EGFR Exon 19 Deletion, +1 more biomarker

Non-Small Cell Lung Carcinoma

amivantamab, +1 more drug

targeted therapy

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

175 sites for NCT04026412

Non-Small Cell Lung Carcinoma

chemoradiotherapy, +3 more drugs

chemotherapy, +2 more types

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

665 sites for NCT03793179

PD-L1 High Expression (TPS >= 1%), +1 more biomarker

Non-Small Cell Lung Carcinoma

carboplatin, +2 more drugs

chemotherapy, +1 more type

Show 574 Trials for Non-Small Cell Lung Carcinoma

atezolizumab